Deng Chen
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- CRISPR and Genetic Engineering
- Gut microbiota and health
Papers in
-
- Ubiquitin and proteasome pathways 7
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 4
- CRISPR and Genetic Engineering 4
- Immunology 15
- Macrophage Migration Inhibitory Factor 11
- Co-authors
- Frank J. Dekker (19 shared papers)Bin Liu (7 shared papers)Hidde J. Haisma (8 shared papers)Fangyuan Cao (3 shared papers)Siwei Chen (5 shared papers)Martijn R. H. Zwinderman (3 shared papers)Dominik Kiemel (1 shared paper)Wim J. Quax (10 shared papers)
- Journals
- Angewandte Chemie International Edition (3 papers)Cancers (3 papers)Journal of Medicinal Chemistry (3 papers)Bioorganic Chemistry (2 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaNetherlandsUnited Kingdom
In The Last Decade
Deng Chen
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 121
- Molecular Medicine 80
- Molecular Biology 581
- Immunology 170
- Oncology 185
- Endocrinology 33
Countries citing papers authored by Deng Chen
This map shows the geographic impact of Deng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deng Chen more than expected).
Fields of papers citing papers by Deng Chen
This network shows the impact of papers produced by Deng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deng Chen. The network helps show where Deng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Deng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 281 | |
| 2 | 2020 | 63 | |
| 3 | 2013 | 43 | |
| 4 | 2019 | 43 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 37 | |
| 7 | 2019 | 36 | |
| 8 | 2009 | 34 | |
| 9 | 2021 | 32 | |
| 10 | 2020 | 25 | |
| 11 | 2021 | 24 | |
| 12 | 2020 | 23 | |
| 13 | 2017 | 22 | |
| 14 | 2022 | 22 | |
| 15 | 2023 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2023 | 19 | |
| 18 | 2021 | 18 | |
| 19 | 2019 | 18 | |
| 20 | 2023 | 18 |
About Deng Chen
Deng Chen is a scholar working on Molecular Biology, Immunology, Oncology, Cellular and Molecular Neuroscience and Epidemiology, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Macrophage Migration Inhibitory Factor (11 papers), Ubiquitin and proteasome pathways (7 papers), Nuclear Receptors and Signaling (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (4 papers), CRISPR and Genetic Engineering (4 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Molecular Medicine (80 citations), Molecular Biology (581 citations), Immunology (170 citations), Oncology (185 citations) and Endocrinology (33 citations). Deng Chen has collaborated with scholars based in China, Netherlands and United Kingdom. Frequent co-authors include Frank J. Dekker, Bin Liu, Hidde J. Haisma, Fangyuan Cao, Siwei Chen, Martijn R. H. Zwinderman, Dominik Kiemel, Wim J. Quax, Petra E. van der Wouden and Zhangping Xiao. Their work appears in journals such as Angewandte Chemie International Edition, Cancers, Journal of Medicinal Chemistry, Bioorganic Chemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.